Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

News & Insights

View allDDup 11PostersPress ReleasePublicationsScientific journalsTechnological insightsTrade journalsWebinarsWhite Papers & Application Notes
Karen Lackey and Jim Thomas

Interview with Dr Jim Thomas and Karen Lackey

DDup 11September 15, 2021

What role do Biologics play in the context of novel therapeutics? Jim: Biologics are a significant and growing portion of the arsenal of therapeutics used…

Learn more
Barbara Bachler-Konetzki

Interview with Barbara Bachler-Konetzki about Evotec’s integrated antibody discovery capabilities

DDup 11September 15, 2021

What were the limitations of previous hybridoma-based approaches? Although the development of the hybridoma technology was a landmark event, the methodology still faced the limitation…

Learn more
Randall Ketchem

Interview with RANDAL R. KETCHEM about the optimization of antibodies

DDup 11September 15, 2021

How does optimization of antibodies improve development? Just – Evotec Biologics has developed a molecular optimisation platform for monoclonal antibodies to increase productivity, eliminate potential…

Learn more

Just – Evotec Biologics Opens J.POD® 1 US in Redmond, Washington

Press ReleaseAugust 11, 2021

J.POD® 1 US provides uniquely flexible cGMP manufacturing of kilograms to metric tons of biologics therapeutics J.POD facility expands Just – Evotec Biologics’ capabilities into commercial…

Learn more

Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse

Press ReleaseApril 20, 2021

J.POD® 2 EU biomanufacturing will play a key role in addressing the need for therapeutic antibodies, including those related to infectious diseases such as COVID-19

Learn more

G-CON Manufacturing and Just – Evotec Biologics Complete the Installation of Cleanroom PODs® for the First J.POD®  Facility in North America

Press ReleaseMarch 16, 2021

Just – Evotec Biologics’ Redmond, Washington site offers true meaning to “Facility of the Future” with flexible and podular manufacturing of clinical and commercial-stage biologics.…

Learn more

Just – Evotec Biologics Expands Contract  With Department of Defense For Manufacturing of Monoclonal Antibodies

Press ReleaseJanuary 27, 2021

Just – Evotec Biologics will manufacture anti-SARS-CoV-2 and other antibodies at its J.POD® manufacturing facility. Access to manufacturing capacity over a period of 7 years

Learn more

Evotec Partners With Alloy Therapeutics  to Expand its Antibody Discovery Platform

Press ReleaseDecember 21, 2020

Evotec gains access to Alloy Therapeutics’ ATX-Gx™ humanised mouse platform for biologics discovery Partnership leverages complementary strengths of in silico, in vitro and in vivo…

Learn more

Just – Evotec Biologics Receives Grant To Enable An Antibody Product For The Prevention Of COVID-19

Press ReleaseOctober 19, 2020

Just – Evotec Biologics receives grant for COVID-19 monoclonal antibody optimisation and cell line development from the COVID-19 therapeutics accelerator Grant enables the optimisation of…

Learn more

Biologics manufacturing without the big bioreactors

Scientific journalsSeptember 28, 2020

Producing therapeutic antibodies is expensive and difficult, but drug-makers have unprecedented flexibility in plant design through a new modular biologics manufacturing platform that streamlines the…

Learn more

Just – Evotec Biologics to Produce Monoclonal Antibody Products Against COVID-19 for The Department of Defense

Press ReleaseJuly 22, 2020

Just – Evotec Biologics to provide process development and manufacturing of monoclonal antibody

Learn more

Just – Evotec Biologics Partners with ABL on Development of Broadly Neutralising Antibody Against HIV

Press ReleaseJune 8, 2020

Just – Evotec Biologics to provide process development required for phase I cGMP clinical manufacturing of broadly neutralising antibody against HIV

Learn more
←12345→
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp